menu search

Algernon pharmaceuticals includes novel salt forms of dmt in its recent ip patent applications

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) told investors that it believes the company has "maximized" its intellectual property (IP) positi...

January 24, 2022, 8:22 am

Algernon pharmaceuticals includes novel salt forms of dmt in its recent ip patent applications

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) told investors that it believes the company has "maximized" its intellectual property (IP) positi...

January 24, 2022, 8:22 am

Signet (sig) posts stellar holiday results & raises view

Signet's (SIG) impressive holiday performance gains from unique banner value offers and novel connected...

January 21, 2022, 4:10 pm

Signet (sig) posts stellar holiday results & raises view

Signet's (SIG) impressive holiday performance gains from unique banner value offers and novel connected...

January 21, 2022, 4:10 pm

Signet (sig) posts stellar holiday results & raises view

Signet's (SIG) impressive holiday performance gains from unique banner value offers and novel connected...

January 21, 2022, 4:10 pm

Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress

LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...

January 21, 2022, 11:04 am

Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress

LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...

January 21, 2022, 11:04 am

Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress

LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...

January 21, 2022, 11:04 am

Cns pharmaceuticals to present at the virtual investor 2022 top picks conference

HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in ...

January 20, 2022, 8:45 am

Cns pharmaceuticals to present at the virtual investor 2022 top picks conference

HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in ...

January 20, 2022, 8:45 am

Cns pharmaceuticals to present at the virtual investor 2022 top picks conference

HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in ...

January 20, 2022, 8:45 am

Marker therapeutics stock gains on fda orphan drug tag for second multitaa-cell therapy for pancreatic cancer

The FDA has granted Orphan Drug Designation to Marker Therapeutics Inc's (NASDAQ: MRKR) MT-601, a multi-tumor-associated antigen (MultiTAA)-specif...

January 20, 2022, 6:38 am

Marker therapeutics stock gains on fda orphan drug tag for second multitaa-cell therapy for pancreatic cancer

The FDA has granted Orphan Drug Designation to Marker Therapeutics Inc's (NASDAQ: MRKR) MT-601, a multi-tumor-associated antigen (MultiTAA)-specif...

January 20, 2022, 6:38 am

Marker therapeutics stock gains on fda orphan drug tag for second multitaa-cell therapy for pancreatic cancer

The FDA has granted Orphan Drug Designation to Marker Therapeutics Inc's (NASDAQ: MRKR) MT-601, a multi-tumor-associated antigen (MultiTAA)-specif...

January 20, 2022, 6:38 am

Obseva to present at the h.c. wainwright bioconnect 2022 conference

GENEVA, Switzerland January 3 , 202 2 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing ...

January 3, 2022, 1:00 am

Obseva to present at the h.c. wainwright bioconnect 2022 conference

GENEVA, Switzerland January 3 , 202 2 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing ...

January 3, 2022, 1:00 am

Obseva to present at the h.c. wainwright bioconnect 2022 conference

GENEVA, Switzerland January 3 , 202 2 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing ...

January 3, 2022, 1:00 am

Genmab: ready for more growth in 2022

Genmab has an impressive pipeline of proprietary and partnered programs in development. In addition, the company has developed or helped develop five ...

December 22, 2021, 11:38 pm

Genmab: ready for more growth in 2022

Genmab has an impressive pipeline of proprietary and partnered programs in development. In addition, the company has developed or helped develop five ...

December 22, 2021, 11:38 pm

Genmab: ready for more growth in 2022

Genmab has an impressive pipeline of proprietary and partnered programs in development. In addition, the company has developed or helped develop five ...

December 22, 2021, 11:38 pm


Search within

Pages Search Results: